What should you open before touring a medical manufacturer?
Read CAPA aging like you read AR aging. A pretty certificate with open majors is a discount. Plan the registration transfer path before LOI. Phase I still applies to the dirt. Do not skip it because the lobby is white.
ISO 13485 certificate and last audit. FDA registration / device listing / establishment identifier. Complaint, CAPA, and change-control files. Process validation packets. Clean-room classification and monitoring logs if claimed. Biocompatibility and sterilization vendors. Whether an asset sale requires a new listing — counsel and a regulatory consultant, not a broker opinion.
| Buyer tab | Open it | If it fails |
|---|---|---|
| Earnings | Tax returns under every add-back | Stop |
| medical device / components pile | CAPA aging read like AR aging | Rewrite the buybox |
| Capital | Path that fits the file | Do not tour |
| People | open majors treated as a discount not a sticker | Price a hire |
How does SBA or cash still fail on a medical device / components plant?
Medical pegs die on validated lots, quarantine, and complaint-related holds. Finished that is awaiting release is not sellable inventory. Customer-owned molds or instruments are bailment. Write classes the QA system already uses. A peg that ignores the quality hold file will invent a cash fight after the wire. Warranty and recall reserves belong in the recast, not as a surprise add-back.
Validated equipment is not a normal VMC. Changing a press or a clean-room monitor can be a validation project. Price that as capex and as downtime. Clean-room classification claims need monitoring logs, not paint color. Useful-life comments are broker practice.
Which medical device / components peg and capex fights belong in the first letter?
Open CAPA aging read like AR aging before you tour a medical manufacturer. A clean medical device / components bay does not replace that tab. If the file cannot produce it, rewrite the buybox. QMS gravity is climate, not permission to skip the work. Put “CAPA aging read like AR aging” on this medical manufacturer buy list.
Underwrite open majors treated as a discount not a sticker the way a lender will on this medical device / components file. Finding it in week eleven is a retrade, not a surprise. SBA 7(a) still caps at $5 million (Source: SBA). The tab still has to fit the box on a medical manufacturer. Put “open majors treated as a discount not a sticker” on this medical manufacturer buy list.
Put registration transfer planned before LOI in the first letter. Tour last. HedgeStone will not invent a medical device / components listing so you can skip that order. A medical manufacturer buybox that cannot name this item is not ready for a plant visit. Put “registration transfer planned before LOI” on this medical manufacturer buy list.
Capital has to match the file. Phase I kept on the dirt is how medical device / components deals die after LOI when nobody opened the tab. Do not apply a neighbor-process multiple because the phrase sounded national. Put “Phase I kept on the dirt” on this medical manufacturer buy list.
People risk on medical device / components often shows up as validated equipment priced as downtime plus capex. Price a hire before you argue the cell. Jason Taken is a business broker. He will not walk a medical manufacturer floor while this item is still a slide. Put “validated equipment priced as downtime plus capex” on this medical manufacturer buy list.
Working-capital fights on a medical manufacturer start when finished awaiting release kept off sellable stock is undefined. Write the method into the letter. Listing path is useful climate. It is not a reason to skip the peg definition. Put “finished awaiting release kept off sellable stock” on this medical manufacturer buy list.
If customer molds treated as bailment fails, rewrite the medical manufacturer buybox before you fall in love with a CIM photo. CAPA aging does not authorize a hope multiple. Tour last. Put “customer molds treated as bailment” on this medical manufacturer buy list.
A first-time medical device / components buyer often tours first and reads complaint-related holds written into the peg later. Reverse that. The letter should already assume the ugly version of this item. Put “complaint-related holds written into the peg” on this medical manufacturer buy list.
Ask who owns biocompatibility vendors confirmed on this medical manufacturer — seller, customer, or folklore. Ownership mistakes become peg mistakes. Write the answer before you count inventory. Put “biocompatibility vendors confirmed” on this medical manufacturer buy list.
Phase I still belongs on many medical device / components plants even when the teaser is about clean-room class matched to logs not paint. Environmental cost does not wait for a pretty machine list. Counsel and a credentialed environmental professional own that lane. Put “clean-room class matched to logs not paint” on this medical manufacturer buy list.
Ninety-day risk after close on medical device / components is often regulatory counsel on listing transfer. If the owner is the only person who can do that work, price a consulting week or a hire in the letter. Put “regulatory counsel on listing transfer” on this medical manufacturer buy list.
After the first five tabs, a medical device / components buyer should know whether a pretty certificate with stale CAPA walked kills the deal. If you still do not know, you toured too early. Book the call with a folder, not a photo. Put “a pretty certificate with stale CAPA walked” on this medical manufacturer buy list.
Write a kill rule for Phase I kept on the dirt in the medical device / components buybox. If the rule is “we will see on the tour,” you do not have a buybox. Listing path is not a kill rule. Put “Phase I kept on the dirt” on this medical manufacturer buy list.
If a lender cannot underwrite validated equipment priced as downtime plus capex, you should not tour the medical manufacturer. Ask the capital path first. CAPA aging does not create a borrowing base. Put “validated equipment priced as downtime plus capex” on this medical manufacturer buy list.
Bring a medical manufacturer process list that already includes finished awaiting release kept off sellable stock. A buyer who cannot name the item will waste a plant visit. Validation cost is not the process list. Put “finished awaiting release kept off sellable stock” on this medical manufacturer buy list.
Inventory and WIP arguments on medical device / components often hide inside customer molds treated as bailment. Demand a class definition before you accept a peg. QMS gravity is not a class. Put “customer molds treated as bailment” on this medical manufacturer buy list.
A second medical manufacturer (a platform add) still has to pass complaint-related holds written into the peg. The first plant’s folklore does not transfer. Listing path does not transfer either. Put “complaint-related holds written into the peg” on this medical manufacturer buy list.
Do not model biocompatibility vendors confirmed as the seller’s problem after close. On medical device / components, it becomes yours the day you wire. Write the cost into the letter. CAPA aging is not a reserve. Put “biocompatibility vendors confirmed” on this medical manufacturer buy list.
Your first medical device / components LOI should already mention clean-room class matched to logs not paint. Finding it after exclusivity is how retrades start. Validation cost is poor LOI language. Put “clean-room class matched to logs not paint” on this medical manufacturer buy list.
After you close a medical device / components plant, regulatory counsel on listing transfer is an operating fact, not a CIM line. Budget the first ninety days as if the ugly version is true. QMS gravity is not a ninety-day plan. Put “regulatory counsel on listing transfer” on this medical manufacturer buy list.
Foreign-buyer calendars (CFIUS, ITAR notice) do not pause because a pretty certificate with stale CAPA walked looked domestic. Read the clocks before exclusivity on a medical device / components plant. Listing path is not a clock. Put “a pretty certificate with stale CAPA walked” on this medical manufacturer buy list.
Job-cost versus quote is the medical device / components earnings test. CAPA aging read like AR aging is how that test usually fails. Open it before you model synergy. CAPA aging is not synergy. Put “CAPA aging read like AR aging” on this medical manufacturer buy list.
Red flags on medical device / components are specific. “I did not like the vibe” is not a flag. Open majors treated as a discount not a sticker is. Write it down. Validation cost is a maybe; this item is not. Put “open majors treated as a discount not a sticker” on this medical manufacturer buy list.
When the first five medical device / components tabs survive, registration transfer planned before LOI is the question that decides whether you keep going. If you cannot answer it, you are not done. QMS gravity is not a sixth tab that replaces it. Put “registration transfer planned before LOI” on this medical manufacturer buy list.
Where does a medical manufacturer buyer go after the first five tabs?
Parent hub: medical device and component manufacturers. Read sell if you need the seller calendar and medical device / components valuation for the cell. Buyer pillar: buy a manufacturing business. Capital box: SBA 7(a) for manufacturing acquisitions.
This medical device / components buyer page will not publish invented listings or skip the first tabs. Counsel, a CPA, and credentialed environmental or M&E professionals own the licensed questions.